Abstract
3D-printed orthopaedic devices and surgical tools, printed maxillofacial implants and other printed acellular devices have been used in patients. By contrast, bioprinted living cellular constructs face considerable translational challenges. In this Perspective, we first summarize the most recent developments in 3D bioprinting for clinical applications, with a focus on how 3D-printed cartilage, bone and skin can be designed for individual patients and fabricated using the patient’s own cells. We then discuss key translational considerations, such as the need to ensure close integration of the living device with the patient’s vascular network, the development of biocompatible bioinks and the challenges in deriving a physiologically relevant number of cells. Lastly, we outline untested regulatory pathways, as well as logistical challenges in material sourcing, manufacturing, standardization and transportation.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Tack, P., Victor, J., Gemmel, P. & Annemans, L. 3D-printing techniques in a medical setting: a systematic literature review. Biomed. Eng. Online 15, 115 (2016).
Di Prima, M., Coburn, J., Hwang, D., Kelly, J., Khairuzzaman, A. & Ricles, L. Additively manufactured medical products–the FDA perspective. 3D Print. Med. 2, 1 (2016).
Ventola, C. L. Medical applications for 3D printing: current and projected uses. Pharma. Ther. 39, 704–711 (2014).
Ma, L. et al. 3D printed personalized titanium plates improve clinical outcome in microwave ablation of bone tumors around the knee. Sci. Rep. 7, 7626 (2017).
Li, B. et al. Application of a novel three-dimensional printing genioplasty template system and its clinical validation: a control study. Sci. Rep. 7, 5431 (2017).
Zopf, D. A., Hollister, S. J., Nelson, M. E., Ohye, R. G. & Green, G. E. Bioresorbable airway splint created with a three-dimensional printer. New Eng. J. Med. 368, 2043–2045 (2013).
Morrison, R. J. et al. Mitigation of tracheobronchomalacia with 3D-printed personalized medical devices in pediatric patients. Sci. Transl. Med. 7, 285–264 (2015).
Highlights of Prescribing Information—Spritam 2015 (FDA, 2017).
Mankin, H. J., Mow, V. C., Buckwalter, J. A., Iannotti, J. P. & Ratcliffe, A. Articular cartilage structure, composition, and function. Orthopaed. Basic Sci. 2, 443–470 (2000).
Buckwalter, J. & Mankin, H. Articular cartilage: tissue design and chondrocyte-matrix interactions. Instr. Course Lect. 47, 477–486 (1998).
Hunziker, E., Quinn, T. & Häuselmann, H.-J. Quantitative structural organization of normal adult human articular cartilage. Osteoarth. Cart. 10, 564–572 (2002).
Sharma, B. et al. Designing zonal organization into tissue-engineered cartilage. Tissue Eng. 13, 405–414 (2007).
Kesti, M. et al. Bioprinting complex cartilaginous structures with clinically compliant biomaterials. Adv. Funct. Mat. 25, 7406–7417 (2015).
Schuurman, W. et al. Gelatin‐methacrylamide hydrogels as potential biomaterials for fabrication of tissue‐engineered cartilage constructs. Macromol. Biosci. 13, 551–561 (2013).
Ávila, H. M., Schwarz, S., Rotter, N. & Gatenholm, P. 3D bioprinting of human chondrocyte-laden nanocellulose hydrogels for patient-specific auricular cartilage regeneration. Bioprinting 1, 22–35 (2016).
Markstedt, K. et al. 3D bioprinting human chondrocytes with nanocellulose–alginate bioink for cartilage tissue engineering applications. Biomacromolecules 16, 1489–1496 (2015).
Hwang, N. S. et al. Response of zonal chondrocytes to extracellular matrix‐hydrogels. FEBS Lett. 581, 4172–4178 (2007).
Coates, E. & Fisher, J. P. Gene expression of alginate‐embedded chondrocyte subpopulations and their response to exogenous IGF‐1 delivery. J. Tissue Eng. Regen. Med. 6, 179–192 (2012).
Cui, X., Breitenkamp, K., Finn, M. G., Lotz, M. & D’Lima, D. D. Direct human cartilage repair using three-dimensional bioprinting technology. Tissue Eng. 18, 1304–1312 (2012).
Gao, G. et al. Improved properties of bone and cartilage tissue from 3D inkjet-bioprinted human mesenchymal stem cells by simultaneous deposition and photocrosslinking in PEG-GelMA. Biotechnol. Lett. 37, 2349 (2015).
Yu, Y. et al. Three-dimensional bioprinting using self-assembling scalable scaffold-free “tissue strands” as a new bioink. Sci. Rep. 6, 28714 (2016).
Levato, R. et al. The bio in the ink: cartilage regeneration with bioprintable hydrogels and articular cartilage-derived progenitor cells. Acta Biomater. 61, 41–53 (2017).
Nguyen, L. H., Kudva, A. K., Saxena, N. S. & Roy, K. Engineering articular cartilage with spatially-varying matrix composition and mechanical properties from a single stem cell population using a multi-layered hydrogel. Biomaterials 32, 6946–6952 (2011).
Nguyen, L. H., Kudva, A. K., Guckert, N. L., Linse, K. D. & Roy, K. Unique biomaterial compositions direct bone marrow stem cells into specific chondrocytic phenotypes corresponding to the various zones of articular cartilage. Biomaterials 32, 1327–1338 (2011).
Nguyen, D. et al. Cartilage tissue engineering by the 3D bioprinting of iPS cells in a nanocellulose/alginate bioink. Sci. Rep. 7, 658 (2017).
Kang, H.-W. et al. A 3D bioprinting system to produce human-scale tissue constructs with structural integrity. Nat. Biotechnol. 34, 312–319 (2016).
Gao, M. et al. Tissue-engineered trachea from a 3D-printed scaffold enhances whole-segment tracheal repair. Sci. Rep. 7, 5246 (2017).
Barbero, A. et al. Age related changes in human articular chondrocyte yield, proliferation and post-expansion chondrogenic capacity. Osteoarth. Cartil. 12, 476–484 (2004).
Huang, A. H., Stein, A., Tuan, R. S. & Mauck, R. L. Transient exposure to transforming growth factor beta 3 improves the mechanical properties of mesenchymal stem cell–laden cartilage constructs in a density-dependent manner. Tissue Eng. 15, 3461–3472 (2009).
Majumdar, M. K., Banks, V., Peluso, D. P. & Morris, E. A. Isolation, characterization, and chondrogenic potential of human bone marrow‐derived multipotential stromal cells. J. Cell. Phys. 185, 98–106 (2000).
Huang, A. H., Farrell, M. J., Kim, M. & Mauck, R. L. Long-term dynamic loading improves the mechanical properties of chondrogenic mesenchymal stem cell-laden hydrogels. Eur. Cell. Mat. 19, 72 (2010).
Shegarfi, H. & Reikeras, O. Bone transplantation and immune response. J. Orthopaed. Surg. 17, 206–211 (2009).
Henkel, J. et al. Bone regeneration based on tissue engineering conceptions—a 21st century perspective. Bone Res. 1, 216 (2013).
Olszta, M. J. et al. Bone structure and formation: a new perspective. Mat. Sci. Eng. Rep. 58, 77–116 (2007).
Bose, S., Vahabzadeh, S. & Bandyopadhyay, A. Bone tissue engineering using 3D printing. Mat. Today 16, 496–504 (2013).
Inzana, J. A. et al. 3D printing of composite calcium phosphate and collagen scaffolds for bone regeneration. Biomaterials 35, 4026–4034 (2014).
Probst, F., Hutmacher, D., Müller, D., Machens, H. & Schantz, J. Calvarial reconstruction by customized bioactive implant. (German trans.) Handchir. Mikrochir. Plast. Chir. 42, 369–373 (2010).
Catros, S. et al. Laser-assisted bioprinting for creating on-demand patterns of human osteoprogenitor cells and nano-hydroxyapatite. Biofabrication 3, 025001 (2011).
Shim, J.-H., Lee, J.-S., Kim, J. Y. & Cho, D.-W. Bioprinting of a mechanically enhanced three-dimensional dual cell-laden construct for osteochondral tissue engineering using a multi-head tissue/organ building system. J. Micromech. Microeng. 22, 085014 (2012).
Shim, J.-H., Kim, J. Y., Park, M., Park, J. & Cho, D.-W. Development of a hybrid scaffold with synthetic biomaterials and hydrogel using solid freeform fabrication technology. Biofabrication 3, 034102 (2011).
Daly, A. C. et al. 3D bioprinting of developmentally inspired templates for whole bone organ engineering. Adv. Health Mater. 5, 2353–2362 (2016).
Lee, W. et al. Multi-layered culture of human skin fibroblasts and keratinocytes through three-dimensional freeform fabrication. Biomaterials 30, 1587–1595 (2009).
Koch, L. et al. Skin tissue generation by laser cell printing. Biotechnol. Bioeng. 109, 1855–1863 (2012).
Michael, S. et al. Tissue engineered skin substitutes created by laser-assisted bioprinting form skin-like structures in the dorsal skin fold chamber in mice. PLoS ONE 8, e57741 (2013).
Lee, W. et al. On‐demand three‐dimensional freeform fabrication of multi‐layered hydrogel scaffold with fluidic channels. Biotechnol. Bioeng. 105, 1178–1186 (2010).
Lee, V. et al. Design and fabrication of human skin by three-dimensional bioprinting. Tissue Eng. Meth. 20, 473–484 (2013).
Cubo, N., Garcia, M., del Cañizo, J. F., Velasco, D. & Jorcano, J. L. 3D bioprinting of functional human skin: production and in vivo analysis. Biofabrication 9, 015006 (2016).
Binder, K. W. In situ bioprinting of the skin. PhD thesis, Wake Forest University (2011).
Albanna, M. et al. In situ bioprinting of autologous skin cells accelerates wound healing of extensive excisional full-thickness wounds. Sci. Rep. 9, 1856 (2019).
Skardal, A. et al. Bioprinted amniotic fluid‐derived stem cells accelerate healing of large skin wounds. Stem Cell. Transl. Med. 1, 792–802 (2012).
Skardal, A. et al. A tunable hydrogel system for long‐term release of cell‐secreted cytokines and bioprinted in situ wound cell delivery. J. Biomed. Mat. Res. Appl. Biomat. 105, 1986–2000 (2017).
Ito, M. et al. Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis. Nat. Med. 11, 1351 (2005).
Hsu, Y.-C., Li, L. & Fuchs, E. Emerging interactions between skin stem cells and their niches. Nat. Med. 20, 847–856 (2014).
Ahn, G. et al. Precise stacking of decellularized extracellular matrix based 3D cell-laden constructs by a 3D cell printing system equipped with heating modules. Sci. Rep. 7, 8624 (2017).
Murphy, S. V., Skardal, A. & Atala, A. Evaluation of hydrogels for bio‐printing applications. J. Biomed. Mat. Res. 101, 272–284 (2013).
Hardin, J. O., Ober, T. J., Valentine, A. D. & Lewis, J. A. Microfluidic printheads for multimaterial 3D printing of viscoelastic inks. Adv. Mater. 27, 3279–3284 (2015).
Ober, T. J., Foresti, D. & Lewis, J. A. Active mixing of complex fluids at the microscale. Proc. Natl. Acad. Sci. USA 112, 12293–12298 (2015).
Cui, H. et al. Hierarchical fabrication of engineered vascularized bone biphasic constructs via dual 3D bioprinting: integrating regional bioactive factors into architectural design. Adv. Health Mater. 5, 2174–2181 (2016).
Merceron, T. K. et al. A 3D bioprinted complex structure for engineering the muscle–tendon unit. Biofabrication 7, 035003 (2015).
Huang, G. et al. Engineering three-dimensional cell mechanical microenvironment with hydrogels. Biofabrication 4, 042001 (2012).
Skardal, A. et al. A hydrogel bioink toolkit for mimicking native tissue biochemical and mechanical properties in bioprinted tissue constructs. Acta Biomater. 25, 24–34 (2015).
Zarembinski, T. I. & Skardal, A. in Hydrogels-Smart Materials for Biomedical Applications (ed. Popa, L.) Ch. 5 (IntechOpen, 2018).
Skardal, A. et al. Photocrosslinkable hyaluronan-gelatin hydrogels for two-step bioprinting. Tissue Eng. 16, 2675 (2010).
Fan, H. et al. Fabrication, mechanical properties, and biocompatibility of graphene-reinforced chitosan composites. Biomacromolecules 11, 2345–2351 (2010).
Zhang, S. Emerging biological materials through molecular self-assembly. Biotechnol. Adv. 20, 321–339 (2002).
Zhang, S. Fabrication of novel biomaterials through molecular self-assembly. Nat. Biotechnol. 21, 1171–1178 (2003).
Gelain, F., Horii, A. & Zhang, S. Designer self‐assembling peptide scaffolds for 3‐D tissue cell cultures and regenerative medicine. Macromol. Biosci. 7, 544–551 (2007).
Mano, J. F. Stimuli‐responsive polymeric systems for biomedical applications. Adv. Eng. Mat. 10, 515–527 (2008).
Karbarz, M., Mackiewicz, M., Kaniewska, K., Marcisz, K. & Stojek, Z. Recent developments in design and functionalization of micro-and nanostructural environmentally-sensitive hydrogels based on N-isopropylacrylamide. Appl. Mat. Today 9, 516–532 (2017).
Liu, X. et al. ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells. Am. J. Path. 180, 599–607 (2012).
Chapman, S., Liu, X., Meyers, C., Schlegel, R. & McBride, A. A. Human keratinocytes are efficiently immortalized by a Rho kinase inhibitor. J. Clin. Investig. 120, 2619 (2010).
Dominici, M. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315–317 (2006).
Pittenger, M. F. et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143–147 (1999).
Zuk, P. A. et al. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell. 13, 4279–4295 (2002).
De Coppi, P. et al. Isolation of amniotic stem cell lines with potential for therapy. Nat. Biotechnol. 25, 100–106 (2007).
Wagner, W. et al. Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS ONE 3, e2213 (2008).
Zhou, S. et al. Age‐related intrinsic changes in human bone‐marrow‐derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell 7, 335–343 (2008).
Choudhery, M. S., Badowski, M., Muise, A., Pierce, J. & Harris, D. T. Donor age negatively impacts adipose tissue-derived mesenchymal stem cell expansion and differentiation. J. Transl. Med. 12, 8 (2014).
Stolzing, A., Jones, E., McGonagle, D. & Scutt, A. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech. Ageing Dev. 129, 163–173 (2008).
Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007).
Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917–1920 (2007).
Kimbrel, E. A. & Lanza, R. Current status of pluripotent stem cells: moving the first therapies to the clinic. Nat. Rev. Drug Discov. 14, 681–692 (2015).
Scudellari, M. How iPS cells changed the world. Nature 534, 310–312 (2016).
Lee, A. S., Tang, C., Rao, M. S., Weissman, I. L. & Wu, J. C. Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies. Nat. Med. 19, 998–1004 (2013).
Trounson, A. & DeWitt, N. D. Pluripotent stem cells progressing to the clinic. Nat. Rev. Mol. Cell Biol. 17, 194–200 (2016).
Mandai, M. et al. Autologous induced stem-cell-derived retinal cells for macular degeneration. New Engl. J. Med. 376, 1038–1046 (2017).
Simonson, O. E., Domogatskaya, A., Volchkov, P. & Rodin, S. The safety of human pluripotent stem cells in clinical treatment. Ann. Med. 47, 370–380 (2015).
Ma, H. et al. Abnormalities in human pluripotent cells due to reprogramming mechanisms. Nature 511, 177–183 (2014).
Okita, K. et al. A more efficient method to generate integration-free human iPS cells. Nat. Methods 8, 409–412 (2011).
Umekage, M., Sato, Y. & Takasu, N. Overview: an iPS cell stock at CiRA. Inflamm. Regen. 39, 17 (2019).
Deegan, D. B., Zimmerman, C., Skardal, A., Atala, A. & Shupe, T. D. Stiffness of hyaluronic acid gels containing liver extracellular matrix supports human hepatocyte function and alters cell morphology. J. Mech. Behav. Biomed. Mater. 55, 87–103 (2016).
Loneker, A. E., Faulk, D. M., Hussey, G. S., D’Amore, A. & Badylak, S. F. Solubilized liver extracellular matrix maintains primary rat hepatocyte phenotype in‐vitro. J. Biomed. Mat. Res. 104, 957–965 (2016).
Kobayashi, J., Akiyama, Y., Yamato, M. & Okano, T. ECM-mimicking thermoresponsive surface for manipulating hepatocyte sheets with maintenance of hepatic functions. in 2016 International Symposium on Micro-NanoMechatronics and Human Science (MHS) (IEEE, 2016)
Huch, M. et al. Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell 160, 299–312 (2015).
Moroni, L. et al. Biofabrication: a guide to technology and terminology. Trends Biotechnol. 36, 348–402 (2017).
Mironov, V. et al. Organ printing: tissue spheroids as building blocks. Biomaterials 30, 2164–2174 (2009).
Jakab, K. et al. Tissue engineering by self-assembly of cells printed into topologically defined structures. Tissue Eng. 14, 413–421 (2008).
Janssen, F. W., Oostra, J., van Oorschot, A. & van Blitterswijk, C. A. A perfusion bioreactor system capable of producing clinically relevant volumes of tissue-engineered bone: in vivo bone formation showing proof of concept. Biomaterials 27, 315–323 (2006).
Brown, D. A. et al. Analysis of oxygen transport in a diffusion‐limited model of engineered heart tissue. Biotechnol. Bioeng. 97, 962–975 (2007).
Jain, R. K., Au, P., Tam, J., Duda, D. G. & Fukumura, D. Engineering vascularized tissue. Nat. Biotechnol. 23, 821–823 (2005).
Muschler, G. F., Nakamoto, C. & Griffith, L. G. Engineering principles of clinical cell-based tissue engineering. JBJS 86, 1541–1558 (2004).
Bertassoni, L. E. et al. Direct-write bioprinting of cell-laden methacrylated gelatin hydrogels. Biofabrication 6, 024105 (2014).
Bertassoni, L. E. et al. Hydrogel bioprinted microchannel networks for vascularization of tissue engineering constructs. Lab Chip 14, 2202–2211 (2014).
Poldervaart, M. T. et al. Prolonged presence of VEGF promotes vascularization in 3D bioprinted scaffolds with defined architecture. J. Contr. Release 184, 58–66 (2014).
Wu, W., DeConinck, A. & Lewis, J. A. Omnidirectional printing of 3D microvascular networks. Adv. Mater. 23, 178–183 (2011).
Ozbolat, I. T. Bioprinting scale-up tissue and organ constructs for transplantation. Trends Biotechnol. 33, 395–400 (2015).
Kolesky, D. B. et al. 3D bioprinting of vascularized, heterogeneous cell‐laden tissue constructs. Adv. Mater. 26, 3124–3130 (2014).
Kolesky, D. B., Homan, K. A., Skylar-Scott, M. A. & Lewis, J. A. Three-dimensional bioprinting of thick vascularized tissues. Proc. Natl Acad. Sci. USA 113, 3179–3184 (2016).
Norotte, C., Marga, F. S., Niklason, L. E. & Forgacs, G. Scaffold-free vascular tissue engineering using bioprinting. Biomaterials 30, 5910–5917 (2009).
Zhu, W. et al. Direct 3D bioprinting of prevascularized tissue constructs with complex microarchitecture. Biomaterials 124, 106–115 (2017).
Hansen, C. J. et al. High‐throughput printing via microvascular multinozzle arrays. Adv. Mater. 25, 96–102 (2013).
Traore, M. A. & George, S. C. Tissue Engineering the Vascular Tree. Tissue Eng. Rev. 23, 505–514 (2017).
Ehsan, S. M. & George, S. C. Nonsteady state oxygen transport in engineered tissue: implications for design. Tissue Eng. 19, 1433–1442 (2013).
Ehsan, S. M. & George, S. C. Vessel network formation in response to intermittent hypoxia is frequency dependent. J. Biosci. Bioeng. 120, 347–350 (2015).
Hsu, Y. H., Moya, M. L., Hughes, C. C., George, S. C. & Lee, A. P. A microfluidic platform for generating large-scale nearly identical human microphysiological vascularized tissue arrays. Lab Chip 13, 2990–2998 (2013).
Tumbleston, J. R. et al. Additive manufacturing: continuous liquid interface production of 3D objects. Science 347, 1349–1352 (2015).
Kengla, C. et al. Clinically relevant bioprinting workflow and imaging process for tssue construct design and validation. 3D Print. Addit. Manuf. 4, 239–247 (2017).
Tibbits, S. Design to self-Assembly. Arch. Des. 82, 68–73 (2012).
Bonamici, S. H. R.34 - 21st Century Cures Act Senate Report 114–146 (United States Congress, 2016).
Technical Considerations for Additive Manufactured Medical Devices - Guidance for Industry and Food and Drug Administration Staff (FDA, 2017).
Hunsberger, J. G., Goel, S., Allickson, J. & Atala, A. Five critical areas that combat high costs and prolonged development times for regenerative medicine manufacturing. Curr. Stem Cell Rep. 3, 77–82 (2017).
Gladman, A. S., Matsumoto, E. A., Nuzzo, R. G., Mahadevan, L. & Lewis, J. A. Biomimetic 4D printing. Nat. Mater. 15, 413–418 (2016).
Kuribayashi-Shigetomi, K., Onoe, H. & Takeuchi, S. Cell origami: self-folding of three-dimensional cell-laden microstructures driven by cell traction force. PLoS ONE 7, e51085 (2012).
Acknowledgements
P.D.C. is supported by the National Institute for Health Research (NIHR-RP-2014-04-046) and by the NIHR Great Ormond Street Hospital Biomedical Research Centre.
Author information
Authors and Affiliations
Contributions
S.V.M, P.D.C and A.A. discussed the content, researched the literature and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Murphy, S.V., De Coppi, P. & Atala, A. Opportunities and challenges of translational 3D bioprinting. Nat Biomed Eng 4, 370–380 (2020). https://doi.org/10.1038/s41551-019-0471-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41551-019-0471-7
This article is cited by
-
Beyond hype: unveiling the Real challenges in clinical translation of 3D printed bone scaffolds and the fresh prospects of bioprinted organoids
Journal of Nanobiotechnology (2024)
-
Hydrogel-mediated extracellular vesicles for enhanced wound healing: the latest progress, and their prospects for 3D bioprinting
Journal of Nanobiotechnology (2024)
-
Cellular reprogramming as a tool to model human aging in a dish
Nature Communications (2024)
-
Unveiling the properties of layered 2D-based nano-material flexible electronics in biomedical applications: a review
Journal of Materials Science (2024)
-
An oxygenating colloidal bioink for the engineering of biomimetic tissue constructs
Bio-Design and Manufacturing (2024)